Due to rises in the cost and use of prescription drugs in 2016 among those insured under health plans available through the Affordable Care Act-created exchanges, the total cost of medications for these individuals rose three times as fast as compared to the prices paid under public and other private plans. Medications for inflammatory and other chronic conditions were responsible for around half of this increased spending, which has also been tied to the broader coverage of exchange plans.